Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2017 Mar 29;7(3):e012665.
doi: 10.1136/bmjopen-2016-012665.

Venous thromboembolism in adults screened for sickle cell trait: a population-based cohort study with nested case-control analysis

Iain Little  1 , Yana Vinogradova  1 , Elizabeth Orton  1 , Joe Kai  1 , Nadeem Qureshi  1
Affiliations
Observational Study

Venous thromboembolism in adults screened for sickle cell trait: a population-based cohort study with nested case-control analysis

Iain Little et al. BMJ Open. .

Abstract

Objective: To determine whether sickle cell carriers ('sickle cell trait') have an increased risk of venous thromboembolism (VTE).

Design: Cohort study with nested case-control analysis.

Setting: General population with data from 609 UK general practices in the Clinical Practice Research Datalink (CPRD).

Participants: All individuals registered with a CPRD general practice between 1998 and 2013, with a medical record of screening for sickle cell between 18 and 75 years of age.

Main outcomes measures: Incidence of VTE per 10 000 person-years (PY) among sickle cell carriers and non-carriers; and adjusted OR for VTE among sickle cell carriers compared with non-carriers.

Results: We included 30 424 individuals screened for sickle cell, with a follow-up time of 179 503 PY, identifying 55 VTEs in 6758 sickle cell carriers and 125 VTEs in 23 666 non-carriers. VTE incidence among sickle cell carriers (14.9/10 000 PY; 95% CI 11.4 to 19.4) was significantly higher than non-carriers (8.8/10 000 PY; 95% CI 7.4 to 10.4). Restricting analysis to confirmed non-carriers was non-significant, but performed on a small sample. In the case-control analysis (180 cases matched to 1775 controls by age and gender), sickle cell carriers remained at increased risk of VTE after adjusting for body mass index, pregnancy, smoking status and ethnicity (OR 1.78, 95% CI 1.18 to 2.69, p=0.006), with the greatest risk for pulmonary embolism (PE) (OR 2.27, 95% CI 1.17 to 4.39, p=0.011).

Conclusions: Although absolute numbers are small, in a general population screened for sickle cell, carriers have a higher incidence and risk of VTE, particularly PE, than non-carriers. Clinicians should be aware of this elevated risk in the clinical care of sickle cell carriers, or when discussing carrier screening, and explicitly attend to modifiable risk factors for VTE in these individuals. More complete primary care coding of carrier status could improve analysis.

Keywords: Venous thromboembolism; cohort study; sickle cell trait;.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Flow chart of patients in the cohort study. CPRD, Clinical Practice Research Datalink; VTE, venous thromboembolism.
See this image and copyright information in PMC

References

    1. Serjeant GR, Serjeant BE. Sickle cell disease. 3rd edn. Oxford: Oxford University Press, 2001.
    1. Tsaras G, Owusu-Ansah A, Boateng F et al. Complications associated with sickle cell trait: a brief narrative review. Am J Med 2009;122:507–12. 10.1016/j.amjmed.2008.12.020 - DOI - PubMed
    1. Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 2008;86:480–7. 10.2471/BLT.06.036673 - DOI - PMC - PubMed
    1. Jordan LB, Smith-Whitley K, Treadwell MJ et al. Screening U.S. college athletes for their sickle cell disease carrier status. Am J Prev Med 2011;41(Suppl 4):S406–12. 10.1016/j.amepre.2011.09.014 - DOI - PubMed
    1. England. PH. NHS Sickle Cell and Thallasaemia programme Fact and Figures. Secondary NHS Sickle Cell and Thallasaemia programme Fact and Figures. http://sct.screening.nhs.uk/statistics

Publication types

LinkOut - more resources